University of Chicago researchers led by Dr. Jing Chen discovered that zeaxanthin, a plant-based nutrient best known for protecting eye health, directly strengthens CD8+ T cells — the immune system's primary cancer killers. The study, published in Cell Reports Medicine, found that zeaxanthin stabilizes T-cell receptors on the cell surface, boosting immune signaling and tumor-killing capacity.
In mouse studies, adding zeaxanthin to the diet slowed tumor growth, with even stronger effects when combined with immune checkpoint inhibitors. When tested with human T cells engineered to target specific cancer markers, zeaxanthin enhanced their ability to destroy melanoma, multiple myeloma, and glioblastoma cells.
The nutrient is already available as an over-the-counter supplement and found naturally in spinach, kale, and orange peppers, making it cheap and accessible. Human clinical trials are the next step. "Our study shows that a simple dietary nutrient could complement and strengthen advanced cancer treatments like immunotherapy," said Dr. Chen.
